Compare Stocks

Cantel Medical Corp. provides infection prevention and control products and services for the healthcare market. The company's Medical segment offers automated endoscope reprocessing systems; disinfectants and sterilants; detergents; leak testing and manual cleaning products; storage cabinets and transport systems; manual cleaning products; endoscope process tracking products; other consumables, accessories, and supplies for use in disinfect rigid endoscopes, flexible endoscopes, and other instrumentation; and technical maintenance services. Its Life Sciences segment provides dialysis water purification and bicarbonate mixing systems; hollow fiber filters, and other filtration and separation products; liquid disinfectants and cold sterilization products; dry fog products; room temperature sterilization equipment and services; and clean-room certification and decontamination services for the dialysis and other healthcare, research laboratories, food and beverage, and commercial industrial customers, as well as microbiological testing services. The company's Dental segment offers hand and powered dental instruments, instrument reprocessing and sterility assurance products, towels, bibs, tray liners, sponges, nitrous oxide/oxygen sedation equipment and related single-use disposable nasal masks, face masks, and shields. It also provides hand sanitizers, germicidal wipes, disinfectants, surface disinfectants, waterline treatment products, saliva ejectors, evacuator tips, plastic cups, prophy angles, and prophy paste. The company's Dialysis segment provides hemodialysis concentrates and other ancillary supplies; medical device reprocessing systems; and sterilants and disinfectants. The company sells its products through its direct distribution network in the United States; and directly or under various third-party distribution agreements internationally. Cantel Medical Corp. was founded in 1963 and is headquartered in Little Falls, New Jersey.

Fort Dearborn Income Securities, Inc. (the Fund) is a diversified closed-end management investment company. The Fund's primary objective is to provide shareholders with a stable stream of current income consistent with external interest rate conditions and provide a total return over time that is above what they could receive by investing individually in the investment grade and long-term maturity sectors of the bond market. The Fund invests in corporate bonds, collateralized debt obligations, commercial mortgage-backed securities, mortgage and agency debt securities, municipal bonds, the United States Government obligations and residential mortgage-backed securities, among others. The Fund has investments in various industry sectors, such as automobiles, banks, biotechnology, building products, capital markets, chemicals, construction materials, consumer finance, diversified financial services and electric utilities. Its investment advisor is UBS Asset Management (Americas), Inc.

GRI Bio, Inc., a clinical-stage biopharmaceutical company, focuses on treating inflammatory, fibrotic, and autoimmune diseases in the United States. Its product pipeline comprises GRI-0621, which is in phase II clinical development for the treatment of idiopathic pulmonary fibrosis; GRI-0803 which is in phase I trial for the treatment of systematic lupus erythematosus; GRI-0124, which is in pre-clinical development for the treatment of primary sclerosing cholangitis; and GRI-0729 in pre-clinical development. The company also develops ADAIR and ADMIR for treatment of attention -deficit/hyperactivity disorder. GRI Bio, Inc. was formerly known as Glycoregimmune, Inc. GRI Bio, Inc. was founded in 2009 and is based in LA Jolla, California.

Silver Spruce Resources Inc., an exploration stage company, engages in the exploration of precious and base minerals. The company primarily explores for silver, lead, zinc, copper, gold, and base and rare earth elements. It holds 100% interest in the Pino de Plata project comprising four concessions covering an area of 397 hectors, located in the prolific Sierra Madre Occidental region of Western Chihuahua State in Mexico; and the Melchett Lake property covering an area of 4,698 hectares located within the English River Sub-province of the Archean-age Superior Province. The company also holds options to acquire 50% interest in the Jackie Gold project covering an area of 1,130 hectares located within the west-central portion of the Sierra Madre Occidental Volcanic Complex; and the Diamante project covering an area of 1,057 hectares located near south-southwest of the towns of Tepoca and Carrizal. In addition, it holds an option to acquire 100% interest in the Mystery project covering an area of 8,750 hectares and located near Grand Falls, Newfoundland, Canada. The company was formerly known as First Labrador Acquisitions Inc. and changed its name to Silver Spruce Resources Inc. in October 2004. Silver Spruce Resources Inc. was incorporated in 1996 and is based in Bedford, Canada.